{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:36:09Z","timestamp":1789828569687,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG2117101"],"award-info":[{"award-number":["RSG2117101"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41391-025-00956-x","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:28:24Z","timestamp":1743028104000},"page":"12-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["New kids on the block: MRI guided transrectal focused US, TULSA, focal laser ablation, histotripsy \u2013 a comprehensive review"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9451-0594","authenticated-orcid":false,"given":"Sangeet","family":"Ghai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany T.","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Pavlovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen J.","family":"Futterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Schade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sanchez-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Cornud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Eggener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Feller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvin K.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnauld","family":"Villers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6308-1763","authenticated-orcid":false,"given":"Jean","family":"de la Rosette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"956_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","volume":"81","author":"JS Hopstaken","year":"2022","unstructured":"Hopstaken JS, Bomers JGR, Sedelaar MJP, Valerio M, F\u00fctterer JJ, Rovers MM. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol. 2022;81:5\u201333.","journal-title":"Eur Urol"},{"key":"956_CR2","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules. 2022;27:5730.","journal-title":"Molecules"},{"key":"956_CR3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.euo.2022.07.004","volume":"5","author":"M Baboudjian","year":"2022","unstructured":"Baboudjian M, Breda A, Rajwa P, Gallioli A, Gondran-Tellier B, Sanguedolce F, et al. Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression. Eur Urol Oncol. 2022;5:617\u201327.","journal-title":"Eur Urol Oncol"},{"key":"956_CR4","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.7150\/thno.23180","volume":"8","author":"P Li","year":"2018","unstructured":"Li P, You S, Nguyen C, Wang Y, Kim J, Sirohi D, et al. Genes involved in prostate cancer progression determine MRI visibility. Theranostics. 2018;8:1752\u201365.","journal-title":"Theranostics"},{"key":"956_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clgc.2022.04.001","volume":"20","author":"AG Wibmer","year":"2022","unstructured":"Wibmer AG, Lefkowitz RA, Lakhman Y, Chaim J, Nikolovski I, Sala E, et al. MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy. Clin Genitourin Cancer. 2022;20:319\u201325.","journal-title":"Clin Genitourin Cancer"},{"key":"956_CR6","doi-asserted-by":"crossref","first-page":"e230431","DOI":"10.1148\/radiol.230431","volume":"309","author":"M Alabousi","year":"2023","unstructured":"Alabousi M, Ghai S, Haider MA. MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer. Radiology. 2023;309:e230431.","journal-title":"Radiology"},{"key":"956_CR7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2214\/AJR.22.28413","volume":"220","author":"S Ghai","year":"2023","unstructured":"Ghai S, Perlis N. Beyond the AJR: MRI-Guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer. Am J Roentgenol. 2023;220:610\u2013610.","journal-title":"Am J Roentgenol"},{"key":"956_CR8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/pcan.2017.8","volume":"20","author":"KJ Tay","year":"2017","unstructured":"Tay KJ, Scheltema MJ, Ahmed HU, Barret E, Coleman JA, Dominguez-Escrig J, et al. Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project. Prostate Cancer Prostatic Dis. 2017;20:294\u20139.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"956_CR9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MOU.0000000000000976","volume":"32","author":"J Jaipuria","year":"2022","unstructured":"Jaipuria J, Ahmed HU. Clinical and pathologic characteristics to select patients for focal therapy or partial gland ablation of nonmetastatic prostate cancer. Curr Opin Urol. 2022;32:224\u201330.","journal-title":"Curr Opin Urol"},{"key":"956_CR10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/JU.0000000000002854","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Boorjian SA, Kirkby E. Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline. J Urol. 2022;208:505\u20137.","journal-title":"J Urol"},{"key":"956_CR11","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2214\/AJR.12.8725","volume":"199","author":"JGR Bomers","year":"2012","unstructured":"Bomers JGR, Sedelaar JPM, Barentsz JO, F\u00fctterer JJ. MRI-Guided Interventions for the Treatment of Prostate Cancer. Am J Roentgenol. 2012;199:714\u201320.","journal-title":"Am J Roentgenol"},{"key":"956_CR12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.juro.2015.02.080","volume":"194","author":"J Le Nobin","year":"2015","unstructured":"Le Nobin J, Rosenkrantz AB, Villers A, Orczyk C, Deng F-M, Melamed J, et al. Image Guided Focal Therapy for Magnetic Resonance Imaging Visible Prostate Cancer: Defining a 3-Dimensional Treatment Margin Based on Magnetic Resonance Imaging Histology Co-Registration Analysis. J Urol. 2015;194:364\u201370.","journal-title":"J Urol"},{"key":"956_CR13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/JU.0000000000001389","volume":"205","author":"A Pooli","year":"2021","unstructured":"Pooli A, Johnson DC, Shirk J, Markovic D, Sadun TY, Sisk AE, et al. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings. J Urol. 2021;205:444\u201351.","journal-title":"J Urol"},{"key":"956_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02656736.2015.1007538","volume":"31","author":"VA Khokhlova","year":"2015","unstructured":"Khokhlova VA, Fowlkes JB, Roberts WW, Schade GR, Xu Z, Khokhlova TD, et al. Histotripsy methods in mechanical disintegration of tissue: towards clinical applications. Int J Hyperthermia. 2015;31:145\u201362.","journal-title":"Int J Hyperthermia"},{"key":"956_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultras.2023.107029","volume":"133","author":"PB Rosnitskiy","year":"2023","unstructured":"Rosnitskiy PB, Tsysar SA, Karzova MM, Buravkov SV, Malkov PG, Danilova NV, et al. Pilot ex vivo study on non-thermal ablation of human prostate adenocarcinoma tissue using boiling histotripsy. Ultrasonics. 2023;133:107029.","journal-title":"Ultrasonics"},{"key":"956_CR16","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.juro.2012.07.006","volume":"188","author":"GR Schade","year":"2012","unstructured":"Schade GR, Keller J, Ives K, Cheng X, Rosol TJ, Keller E, et al. Histotripsy focal ablation of implanted prostate tumor in an ACE-1 canine cancer model. J Urol. 2012;188:1957\u201364.","journal-title":"J Urol"},{"key":"956_CR17","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00270-013-0592-4","volume":"36","author":"A Napoli","year":"2013","unstructured":"Napoli A, Anzidei M, Ciolina F, Marotta E, Cavallo Marincola B, Brachetti G, et al. MR-guided high-intensity focused ultrasound: current status of an emerging technology. Cardiovasc Intervent Radiol. 2013;36:1190\u2013203.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"956_CR18","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1007\/s00330-018-5409-z","volume":"28","author":"S Ghai","year":"2018","unstructured":"Ghai S, Perlis N, Lindner U, Hlasny E, Haider MA, Finelli A, et al. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial. Eur Radiol. 2018;28:4281\u20137.","journal-title":"Eur Radiol"},{"key":"956_CR19","doi-asserted-by":"crossref","first-page":"W177","DOI":"10.2214\/AJR.14.13098","volume":"205","author":"S Ghai","year":"2015","unstructured":"Ghai S, Louis AS, Van Vliet M, Lindner U, Haider MA, Hlasny E, et al. Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes. AJR Am J Roentgenol. 2015;205:W177\u2013184.","journal-title":"AJR Am J Roentgenol"},{"key":"956_CR20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0090-4295(96)00233-6","volume":"48","author":"E Orihuela","year":"1996","unstructured":"Orihuela E, Pow-Sang M, Motamedi M, Cowan DF, Warren MM. Mechanism of healing of the human prostatic urethra following thermal injury. Urology. 1996;48:600\u20138.","journal-title":"Urology"},{"key":"956_CR21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1148\/radiol.2017161650","volume":"285","author":"KJ Tay","year":"2017","unstructured":"Tay KJ, Cheng CWS, Lau WKO, Khoo J, Thng CH, Kwek JW. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes. Radiology. 2017;285:620\u20138.","journal-title":"Radiology"},{"key":"956_CR22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S1470-2045(22)00251-0","volume":"23","author":"B Ehdaie","year":"2022","unstructured":"Ehdaie B, Tempany CM, Holland F, Sjoberg DD, Kibel AS, Trinh Q-D, et al. MRI-Guided Focused Ultrasound (MRgFUS) Focal Therapy for Intermediate-Risk Prostate Cancer: A Phase 2b Multicenter Study. Lancet Oncol. 2022;23:910\u20138.","journal-title":"Lancet Oncol"},{"key":"956_CR23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1148\/radiol.2021202717","volume":"298","author":"S Ghai","year":"2021","unstructured":"Ghai S, Finelli A, Corr K, Chan R, Jokhu S, Li X, et al. MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. Radiology. 2021;298:695\u2013703.","journal-title":"Radiology"},{"key":"956_CR24","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231473","volume":"310","author":"S Ghai","year":"2024","unstructured":"Ghai S, Finelli A, Corr K, Lajkosz K, McCluskey S, Chan R, et al. MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial. Radiology. 2024;310:e231473.","journal-title":"Radiology"},{"key":"956_CR25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/17434440.2020.1755258","volume":"17","author":"A Napoli","year":"2020","unstructured":"Napoli A, Alfieri G, Scipione R, Leonardi A, Fierro D, Panebianco V, et al. High-intensity focused ultrasound for prostate cancer. Expert Rev Med Devices. 2020;17:427\u201333.","journal-title":"Expert Rev Med Devices"},{"key":"956_CR26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.eururo.2015.01.030","volume":"68","author":"HU Ahmed","year":"2015","unstructured":"Ahmed HU, Dickinson L, Charman S, Weir S, McCartan N, Hindley RG, et al. Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study. Eur Urol. 2015;68:927\u201336.","journal-title":"Eur Urol"},{"key":"956_CR27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2015.06.018","volume":"69","author":"ERC Feijoo","year":"2016","unstructured":"Feijoo ERC, Sivaraman A, Barret E, Sanchez-Salas R, Galiano M, Rozet F, et al. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Eur Urol. 2016;69:214\u201320.","journal-title":"Eur Urol"},{"key":"956_CR28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00345-020-03297-7","volume":"39","author":"PM Huber","year":"2021","unstructured":"Huber PM, Afzal N, Arya M, Boxler S, Dudderidge T, Emberton M, et al. Focal HIFU therapy for anterior compared to posterior prostate cancer lesions. World J Urol. 2021;39:1115\u20139.","journal-title":"World J Urol"},{"key":"956_CR29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2015.12.029","volume":"70","author":"JL Chin","year":"2016","unstructured":"Chin JL, Billia M, Relle J, Roethke MC, Popeneciu IV, Kuru TH, et al. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial. Eur Urol. 2016;70:447\u201355.","journal-title":"Eur Urol"},{"key":"956_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1148\/radiol.12112263","volume":"265","author":"R Chopra","year":"2012","unstructured":"Chopra R, Colquhoun A, Burtnyk M, N\u2019djin WA, Kobelevskiy I, Boyes A, et al. MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. Radiology. 2012;265:303\u201313.","journal-title":"Radiology"},{"key":"956_CR31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/bju.15268","volume":"127","author":"SM Nair","year":"2021","unstructured":"Nair SM, Hatiboglu G, Relle J, Hetou K, Hafron J, Harle C, et al. Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study. BJU Int. 2021;127:544\u201352.","journal-title":"BJU Int"},{"key":"956_CR32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/JU.0000000000001362","volume":"205","author":"L Klotz","year":"2021","unstructured":"Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, et al. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer. J Urol. 2021;205:769\u201379.","journal-title":"J Urol"},{"key":"956_CR33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.juro.2016.06.100","volume":"197","author":"E Ramsay","year":"2017","unstructured":"Ramsay E, Mougenot C, Staruch R, Boyes A, Kazem M, Bronskill M, et al. Evaluation of focal ablation of MRI-defined prostate cancer using MRI-controlled transurethral ultrasound therapy with prostatectomy as the reference standard. J Urol. 2017;197:255\u201361.","journal-title":"J Urol"},{"key":"956_CR34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/21681805.2019.1660707","volume":"53","author":"M Anttinen","year":"2019","unstructured":"Anttinen M, M\u00e4kel\u00e4 P, Suomi V, Kiviniemi A, Saunavaara J, Sainio T, et al. Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer. Scand J Urol. 2019;53:295\u2013302.","journal-title":"Scand J Urol"},{"key":"956_CR35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euros.2020.10.007","volume":"22","author":"M Anttinen","year":"2020","unstructured":"Anttinen M, M\u00e4kel\u00e4 P, Viitala A, Nurminen P, Suomi V, Sainio T, et al. Salvage Magnetic Resonance Imaging\u2013guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results. Eur Urol Open Sci. 2020;22:79\u201387.","journal-title":"Eur Urol Open Sci"},{"key":"956_CR36","first-page":"55","volume":"16","author":"T Lee","year":"2014","unstructured":"Lee T, Mendhiratta N, Sperling D, Lepor H. Focal Laser Ablation for Localized Prostate Cancer: Principles, Clinical Trials, and Our Initial Experience. Rev Urol. 2014;16:55\u201366.","journal-title":"Rev Urol"},{"key":"956_CR37","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1148\/radiol.13121652","volume":"267","author":"A Oto","year":"2013","unstructured":"Oto A, Sethi I, Karczmar G, McNichols R, Ivancevic MK, Stadler WM, et al. MR imaging-guided focal laser ablation for prostate cancer: phase I trial. Radiology. 2013;267:932\u201340.","journal-title":"Radiology"},{"key":"956_CR38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/end.2009.0440","volume":"24","author":"U Lindner","year":"2010","unstructured":"Lindner U, Lawrentschuk N, Trachtenberg J. Focal laser ablation for localized prostate cancer. J Endourol. 2010;24:791\u20137.","journal-title":"J Endourol"},{"key":"956_CR39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.eururo.2010.03.008","volume":"57","author":"U Lindner","year":"2010","unstructured":"Lindner U, Lawrentschuk N, Weersink RA, Davidson SRH, Raz O, Hlasny E, et al. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. Eur Urol. 2010;57:1111\u20134.","journal-title":"Eur Urol"},{"key":"956_CR40","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.juro.2009.06.035","volume":"182","author":"U Lindner","year":"2009","unstructured":"Lindner U, Weersink RA, Haider MA, Gertner MR, Davidson SRH, Atri M, et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol. 2009;182:1371\u20137.","journal-title":"J Urol"},{"key":"956_CR41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eururo.2010.03.006","volume":"58","author":"O Raz","year":"2010","unstructured":"Raz O, Haider MA, Davidson SRH, Lindner U, Hlasny E, Weersink R, et al. Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. Eur Urol. 2010;58:173\u20137.","journal-title":"Eur Urol"},{"key":"956_CR42","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.juro.2016.07.074","volume":"196","author":"SE Eggener","year":"2016","unstructured":"Eggener SE, Yousuf A, Watson S, Wang S, Oto A. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer. J Urol. 2016;196:1670\u20135.","journal-title":"J Urol"},{"key":"956_CR43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.eururo.2015.04.029","volume":"68","author":"H Lepor","year":"2015","unstructured":"Lepor H, Llukani E, Sperling D, F\u00fctterer JJ. Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer. Eur Urol. 2015;68:924\u20136.","journal-title":"Eur Urol"},{"key":"956_CR44","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/ans.15526","volume":"89","author":"Y Al-Hakeem","year":"2019","unstructured":"Al-Hakeem Y, Raz O, Gacs Z, Maclean F, Varol C. Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy. ANZ J Surg. 2019;89:1610\u20134.","journal-title":"ANZ J Surg"},{"key":"956_CR45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jvir.2018.09.016","volume":"30","author":"E Walser","year":"2019","unstructured":"Walser E, Nance A, Ynalvez L, Yong S, Aoughsten JS, Eyzaguirre EJ, et al. Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low to Intermediate Risk Disease. J Vasc Interv Radiol. 2019;30:401\u20139.e2.","journal-title":"J Vasc Interv Radiol"},{"key":"956_CR46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.urology.2021.03.054","volume":"155","author":"B Chao","year":"2021","unstructured":"Chao B, Lepor H. 5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer. Urology. 2021;155:124\u20139.","journal-title":"Urology"},{"key":"956_CR47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5152\/dir.2021.20095","volume":"27","author":"S Mehralivand","year":"2021","unstructured":"Mehralivand S, George AK, Hoang AN, Rais-Bahrami S, Rastinehad AR, Lebastchi AH, et al. MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up. Diagn Interv Radiol. 2021;27:394\u2013400.","journal-title":"Diagn Interv Radiol"},{"key":"956_CR48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clinimag.2021.04.014","volume":"76","author":"D Magee","year":"2021","unstructured":"Magee D, Perlis N, Corr K, Chan R, Gertner M, Zisman A, et al. Salvage interstitial laser thermal therapy under MRI guidance (MRgFLA) for high-intensity focal ultrasound (HIFU) recurrences: feasibility study. Clin Imaging. 2021;76:217\u201321.","journal-title":"Clin Imaging"},{"key":"956_CR49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.juro.2017.04.017","volume":"198","author":"S Natarajan","year":"2017","unstructured":"Natarajan S, Jones TA, Priester AM, Geoghegan R, Lieu P, Delfin M, et al. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance. J Urol. 2017;198:839\u201347.","journal-title":"J Urol"},{"key":"956_CR50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.euros.2022.02.012","volume":"39","author":"LAMJG van Riel","year":"2022","unstructured":"van Riel LAMJG, van Kollenburg RAA, Vis AN, van Leeuwen PJ, de Reijke TM, de Bruin DM, et al. Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study. Eur Urol Open Sci. 2022;39:48\u201354.","journal-title":"Eur Urol Open Sci"},{"key":"956_CR51","unstructured":"Genesis Research LLC. Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging. 2023. https:\/\/clinicaltrials.gov\/study\/NCT05826470. Accessed 31 Dec 2023."},{"key":"956_CR52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1148\/radiol.212163","volume":"305","author":"S Ghai","year":"2022","unstructured":"Ghai S, Perlis N, Atallah C, Jokhu S, Corr K, Lajkosz K, et al. Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men. Radiology. 2022;305:390\u20138.","journal-title":"Radiology"},{"key":"956_CR53","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1007\/s00330-020-06882-x","volume":"30","author":"F Cornud","year":"2020","unstructured":"Cornud F, Lefevre A, Flam T, Dumonceau O, Galiano M, Soyer P, et al. MRI-directed high-frequency (29MhZ) TRUS-guided biopsies: initial results of a single-center study. Eur Radiol. 2020;30:4838.","journal-title":"Eur Radiol"},{"key":"956_CR54","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MOU.0000000000000044","volume":"24","author":"H Wenger","year":"2014","unstructured":"Wenger H, Yousuf A, Oto A, Eggener S. Laser Ablation as Focal Therapy for Prostate Cancer. Curr Opin Urol. 2014;24:236\u201340.","journal-title":"Curr Opin Urol"},{"key":"956_CR55","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00345-019-02636-7","volume":"37","author":"A van Luijtelaar","year":"2019","unstructured":"van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR, et al. Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project. World J Urol. 2019;37:2147\u201353.","journal-title":"World J Urol"},{"key":"956_CR56","unstructured":"University Health Network, Toronto. MRI Guided Focal Laser Ablation of Prostate Cancer. 2020. https:\/\/clinicaltrials.gov\/study\/NCT03650595. Accessed 31 Dec 2023."},{"key":"956_CR57","unstructured":"Radboud University Medical Center. Magnetic Resonance Imaging-guided Focal Laser Ablation of Prostate Cancer. 2022. https:\/\/clinicaltrials.gov\/study\/NCT05370482. Accessed 31 Dec 2023."},{"key":"956_CR58","unstructured":"Woodrum DA. A Pilot Study to Evaluate Magnetic Resonance Thermal Image-Guided Focal Laser Ablation of Prostate Cancer Tumors. 2023. https:\/\/clinicaltrials.gov\/study\/NCT02600156. Accessed 31 Dec 2023."},{"key":"956_CR59","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jum.15191","volume":"39","author":"TJ Dubinsky","year":"2020","unstructured":"Dubinsky TJ, Khokhlova TD, Khokhlova V, Schade GR. Histotripsy: The Next Generation of High-Intensity Focused Ultrasound for Focal Prostate Cancer Therapy. J Ultrasound Med. 2020;39:1057\u201367.","journal-title":"J Ultrasound Med"},{"key":"956_CR60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ultrasmedbio.2005.09.005","volume":"32","author":"JE Parsons","year":"2006","unstructured":"Parsons JE, Cain CA, Abrams GD, Fowlkes JB. Pulsed cavitational ultrasound therapy for controlled tissue homogenization. Ultrasound Med Biol. 2006;32:115\u201329.","journal-title":"Ultrasound Med Biol"},{"key":"956_CR61","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1121\/1.3626152","volume":"130","author":"TD Khokhlova","year":"2011","unstructured":"Khokhlova TD, Canney MS, Khokhlova VA, Sapozhnikov OA, Crum LA, Bailey MR. Controlled tissue emulsification produced by high intensity focused ultrasound shock waves and millisecond boiling. J Acoust Soc Am. 2011;130:3498\u2013510.","journal-title":"J Acoust Soc Am"},{"key":"956_CR62","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ultrasmedbio.2018.10.035","volume":"45","author":"KB Bader","year":"2019","unstructured":"Bader KB, Vlaisavljevich E, Maxwell AD. For Whom the Bubble Grows: Physical Principles of Bubble Nucleation and Dynamics in Histotripsy Ultrasound Therapy. Ultrasound Med Biol. 2019;45:1056\u201380.","journal-title":"Ultrasound Med Biol"},{"key":"956_CR63","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1088\/0031-9155\/57\/23\/8061","volume":"57","author":"JC Simon","year":"2012","unstructured":"Simon JC, Sapozhnikov OA, Khokhlova VA, Wang Y-N, Crum LA, Bailey MR. Ultrasonic atomization of tissue and its role in tissue fractionation by high intensity focused ultrasound. Phys Med Biol. 2012;57:8061\u201378.","journal-title":"Phys Med Biol"},{"key":"956_CR64","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/09553002.2015.1021962","volume":"91","author":"J Luo","year":"2015","unstructured":"Luo J, Ren X, Yu T. Efficacy of extracorporeal ultrasound-guided high intensity focused ultrasound: An evaluation based on controlled trials in China. Int J Radiat Biol. 2015;91:480\u20135.","journal-title":"Int J Radiat Biol"},{"key":"956_CR65","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.1318355111","volume":"111","author":"TD Khokhlova","year":"2014","unstructured":"Khokhlova TD, Wang Y-N, Simon JC, Cunitz BW, Starr F, Paun M, et al. Ultrasound-guided tissue fractionation by high intensity focused ultrasound in an in vivo porcine liver model. Proc Natl Acad Sci USA. 2014;111:8161\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"956_CR66","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1109\/TUFFC.2018.2825233","volume":"65","author":"M Lafond","year":"2018","unstructured":"Lafond M, Asquier N, Mestas J-LA, Carpentier A, Umemura S-I, Lafon C. Evaluation of a Three-Hydrophone Method for 2-D Cavitation Localization. IEEE Trans Ultrason Ferroelectr Freq Control. 2018;65:1093\u2013101.","journal-title":"IEEE Trans Ultrason Ferroelectr Freq Control"},{"key":"956_CR67","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.urology.2009.03.049","volume":"74","author":"TL Hall","year":"2009","unstructured":"Hall TL, Hempel CR, Wojno K, Xu Z, Cain CA, Roberts WW. Histotripsy of the prostate: dose effects in a chronic canine model. Urology. 2009;74:932\u20137.","journal-title":"Urology"},{"key":"956_CR68","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.urology.2008.01.037","volume":"72","author":"AM Lake","year":"2008","unstructured":"Lake AM, Hall TL, Kieran K, Fowlkes JB, Cain CA, Roberts WW. Histotripsy: minimally invasive technology for prostatic tissue ablation in an in vivo canine model. Urology. 2008;72:682\u20136.","journal-title":"Urology"},{"key":"956_CR69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.urology.2009.09.021","volume":"75","author":"JC Wheat","year":"2010","unstructured":"Wheat JC, Hall TL, Hempel CR, Cain CA, Xu Z, Roberts WW. Prostate histotripsy in an anticoagulated model. Urology. 2010;75:207\u201311.","journal-title":"Urology"},{"key":"956_CR70","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.juro.2010.11.044","volume":"185","author":"CR Hempel","year":"2011","unstructured":"Hempel CR, Hall TL, Cain CA, Fowlkes JB, Xu Z, Roberts WW. Histotripsy fractionation of prostate tissue: local effects and systemic response in a canine model. J Urol. 2011;185:1484\u20139.","journal-title":"J Urol"},{"key":"956_CR71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/end.2011.0349","volume":"26","author":"GR Schade","year":"2012","unstructured":"Schade GR, Styn NR, Hall TL, Roberts WW. Endoscopic assessment and prediction of prostate urethral disintegration after histotripsy treatment in a canine model. J Endourol. 2012;26:183\u20139.","journal-title":"J Endourol"},{"key":"956_CR72","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.urology.2012.05.027","volume":"80","author":"GR Schade","year":"2012","unstructured":"Schade GR, Hall TL, Roberts WW. Urethral-sparing histotripsy of the prostate in a canine model. Urology. 2012;80:730\u20135.","journal-title":"Urology"},{"key":"956_CR73","unstructured":"Radboud University Medical Center. Effectiveness of Focal Therapy in Men With Prostate Cancer. 2024. https:\/\/clinicaltrials.gov\/study\/NCT06223295. Accessed 31 Dec 2023."},{"key":"956_CR74","unstructured":"Baco E. A Randomized Control Trial of Focal Prostate Ablation Versus Radical Prostatectomy. 2021. https:\/\/clinicaltrials.gov\/study\/NCT03668652. Accessed 31 Dec 2023."}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00956-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00956-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00956-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:06:07Z","timestamp":1771272367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00956-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["956"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-00956-x","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SG served as Principal Investigator for Phase I and Phase II studies assessing MRgFUS sponsored by Insightec Ltd. GS currently serves as a consultant to EDAP Technomed Inc., an advisor to Immunity Bio, owns intellectual property licensed to Petal Surgical, and his work has been funded by the NIH (NIH R01DK119310 and R01CA258581) and American Cancer Society (RSG2117101). SE previously served as a member of the medical advisory board for Profound Medical approximately from the years 2016-2020. All other co-authors declare no potential competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}